Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
---|
08/07/2008 | WO2008093614A1 Novel hepatitis c virus inhibitor |
08/07/2008 | WO2008092944A1 Organic molybdenum compounds and oil compositions containing the same |
08/07/2008 | US20080188655 Monomer With Anti-Microbial Character, Polymer Using The Same, And Manufacturing Method Thereof |
08/07/2008 | US20080188654 Compounds for treatment of inflammation, diabetes and related disorders |
08/07/2008 | US20080188529 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
08/07/2008 | US20080188522 4-Methylpropiophenone reacted with piperidine hydrochloride and 1,3-dioxolane in the presence of an acid catalyst, and the tolperisone obtained in the form of an acid addition salt is separated by filtering after the reaction mixture has cooled down; improved purity, simplification |
08/07/2008 | US20080188489 Cell differentiation inducer |
08/07/2008 | US20080188486 e.g. (1-cyclopentylmethyl-1H-indol-5-yl)-(4-isopropyl-piperazin-1-yl)-methanone; antagonists and/or inverse agonists at the histamine 3 receptor; antidepressant, anxiolytic agent; obesity, cardiovascular disorders |
08/07/2008 | US20080188475 Perhydro- or hydrophenanthrene derivatives; antiinflammatory, analgesic, anticarcinogenic, and antitumor agents; autoimmune, skin, cardiovascular, and viral diseases |
08/07/2008 | US20080188462 reversed chloroquines; to treat chloroquine resistant/sensitive malaria parasites; N'-(7-Chloro-quinolin-4-yl)-N-[3-(10,11-dihydro-dibenzo[b,f]azepin-5-yl)-propyl]-N-methyl-propane-1,3-diamine |
08/07/2008 | US20080188460 Tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them |
08/07/2008 | US20080187978 Anti-inflammatory medicaments |
08/07/2008 | DE102007004698A1 Verbindungen enthaltend Organofluorochlorophosphatanionen Compounds containing Organofluorochlorophosphatanionen |
08/06/2008 | EP1953142A1 Process for the preparation of antihistaminic 4-diphenylmethyl piperidine derivatives |
08/06/2008 | EP1951719A2 Certain chemical entities, compositions, and methods |
08/06/2008 | EP1951700A2 Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives |
08/06/2008 | EP1951699A2 Processes for the preparation of cyclopropyl-amide derivatives |
08/06/2008 | EP1951698A1 Iap bir domain binding compounds |
08/06/2008 | EP1951663A2 (r)-arylkylamino derivatives and pharmaceutical compositions containing them |
08/06/2008 | EP1568702A4 Palladium complexes with heterocyclic ligands |
08/06/2008 | EP1397382B1 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions |
08/06/2008 | EP1311475B1 Aminocyclohexane derivatives |
08/06/2008 | CN101235020A Substituted cinnamamide derivatives and application of the same as nerve protecting agent |
08/06/2008 | CN101235019A 3,5-diiodo salicylaldehyde-4-(omega-aminoalkyl)morpholine metal complexes, preparation method and use thereof |
08/06/2008 | CN100408539C Vitamin d receptor modulators |
08/05/2008 | US7408008 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
08/05/2008 | US7407974 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
08/05/2008 | US7407956 Benzamide inhibitors of the P2X7 receptor |
08/05/2008 | US7407648 Protecting human and animal hair or skin from UV radiation by applying a 4,4-disubstituted -1,3-butadienylamine; 4,4-substituents may be the same or different and are cyano, ester, sec. or tert. amide, ketone and/or sulfone, e.g., 4,4-bis(hexyloxycarbonyl)-N,N-diethyl-1,3-butadienylamine |
08/05/2008 | US7407516 variety of molecules used as oxidation bases and couplers allows a wide range of colors to be obtained; hair dye |
08/05/2008 | CA2337098C Anthranilic acid derivatives |
08/05/2008 | CA2223595C Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
07/31/2008 | WO2008090429A1 Tosylate salt of a therapeutic compound and pharmaceutical compositions thereof |
07/31/2008 | WO2008090357A2 N, n; -substituted piperazines binding to melanocortin receptor |
07/31/2008 | US20080182993 chemical intermediate is 4-(3,5-bi (1,1- dimethylethyl-4-hydroxyphenyl)-N-methyl-2-thiazolemethylamine |
07/31/2008 | US20080182875 N-(2-Hydroxyethyl)-N-Methyl-4-(Quinolin-8-yl(1-(Thiazol-4-ylmethyl)Piperidin-4-ylidene)Methyl)Benzamide |
07/31/2008 | US20080182837 New chemical compounds |
07/31/2008 | US20080182798 Novel effectors of dipeptidyl peptidase IV |
07/31/2008 | DE102007010815B3 New N-phenylsulfonyl-3-amidino-phenylalanine piperidide derivatives useful as antitumor agents |
07/30/2008 | EP1948630A2 Novel compounds |
07/30/2008 | EP1948629A1 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
07/30/2008 | EP1948627A1 Novel dual peptidase inhibitors as prodrugs for the therapy of inflammatory and other disorders |
07/30/2008 | EP1948626A1 Process for the preparation of delmopinol and derivatives thereof |
07/30/2008 | EP1948607A2 Cyclopropyl amines as modulators of the histamine h3 receptor |
07/30/2008 | EP1254124B1 Dipeptide nitrile cathepsin k inhibitors |
07/30/2008 | CN101233121A PARP modulators and treatment of cancer |
07/30/2008 | CN101230051A Method for preparing S-(alpha, alpha-dimethyl benzyl) piperidine-1-thiocarboxylic |
07/30/2008 | CN101230023A Method for preparing azo onium diol sodium salt |
07/30/2008 | CN101230015A Substituted cinnamic acid derivatives containing amine substituent group and expression purification cytotoxicity thereof |
07/30/2008 | CN100407493C 非水电解质和非水电解质二次电池 The non-aqueous electrolyte and a nonaqueous electrolyte secondary battery |
07/30/2008 | CN100406449C CDC25 phosphatase inhibitors |
07/30/2008 | CN100406448C Pseudopolymorphic forms of z-[2-[4-(bis(4-fluorophenyl)methyl]-1-piperazinyl]ethozy] acetic and dihydrochloride |
07/30/2008 | CN100406431C Ionic liquid electrolyte salt for storage device electrolytic solution for storage device electric double layer capacitor and secondary battery |
07/30/2008 | CN100406007C Asthma and allergic inflammation modulators |
07/29/2008 | US7405327 Method for the continuous production of an amine |
07/29/2008 | US7405230 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs |
07/29/2008 | CA2361464C Compounds comprising acrylate and cyclic sec.-amine functionalities |
07/29/2008 | CA2262997C Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells |
07/29/2008 | CA2218096C New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
07/29/2008 | CA2214323C Compounds and compositions for delivering active agents |
07/29/2008 | CA2175767C Adhesion receptor antagonists |
07/29/2008 | CA2168192C 4-aminobenzoylguanidine derivatives |
07/24/2008 | WO2008087654A2 PIPERIDINES AS INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 |
07/24/2008 | WO2007035425A3 Cyclopropyl amines as modulators of the histamine h3 receptor |
07/24/2008 | US20080177071 Process for the preparation of 2- (2- (4- (bis (4-flourophenyl) methyl) -pipe razin-1-yl) ethoxy acetic acid derivatives or corresponding salt forms thereof and intermediates therefor |
07/24/2008 | US20080176856 Novel Alkyl Substituted Piperidine Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors |
07/24/2008 | US20080176854 Nitro-Substituted Phenyl-Piperazine Compounds, Their Preparation and Use in Medicaments |
07/24/2008 | US20080176849 e.g. N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]-amino]methyl]phenyl]-2E-2-propenamide; histone deacetylase inhibitor; anticarcinogenic, antitumor, antiproliferative agents; improved stability |
07/24/2008 | US20080176842 N1-[1-[N-(2-methylpropyl)-N-(phenylsulfonyl)amino]-2R-hydroxy-3S-(phenylmethyl)prop-3-yl]-3-(1-morpholinosulfonyl)-2R-methylpropionamide; viricide; human T-cell leukemia/limphoma virus |
07/24/2008 | US20080176841 (amidomethyl-amido)-(carboxy/amido)epoxide derivatives; cathepsin inhibitor; antiinflammatory, anticarcinogenic, antidiabeticagent, antiallergen, autoimmune and neurodegenerative disorders |
07/24/2008 | US20080176833 Dihydropyridine derivatives as useful as protein kinase inhibitors |
07/24/2008 | US20080176763 Collection of Traceable Compounds and Uses Thereof |
07/24/2008 | US20080175795 e.g. 3-{4-[4-(2-amino-2-carbamoyl-ethyl)-phenoxy]-phenyl)-propionic acid; antiinflammatory and immunological diseases, cytokines (TNF- alpha , IL-1, IL-6), orexin, nitric oxide synthase inhibitor; obesity, hyperlipidemia, migraine, asthma, chronic obstructive pulmonary disease, osteoarthritis |
07/23/2008 | EP1947093A1 Substituted morpholine and thiomorpholine derivatives |
07/23/2008 | EP1945621A1 Process to prepare amino acid derivatives |
07/23/2008 | EP1945609A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
07/23/2008 | EP1945606A1 Alkylcarbamoyl naphthalenyloxy- octenoylhydroxyamide derivatives having inhibitory activity against histone deacetylase and preparation thereof |
07/23/2008 | EP1846384B1 Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine |
07/23/2008 | EP1735267B1 Aminoalkyl substituted esters and amides of fumaric acid for neutralising malodor |
07/23/2008 | EP1070070B1 Method for producing grignard compounds |
07/23/2008 | CN101228145A Organic compounds for the treatment of inflammatory or allergic conditions |
07/23/2008 | CN101225075A Cinepazide maleate crystal system and method for making same |
07/22/2008 | US7402704 Arylsulfones and uses related thereto |
07/22/2008 | US7402698 1-[2-(benzylamino)-1-(3,4-dichlorophenyl)ethyl]cyclobutanol hydrochloride; norepinephrine reuptake inhibitor; antidepressant, analgesic; vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, sleep disorder, hormone replacement syndrome |
07/22/2008 | CA2481246C Compounds that modulate ppar activity and methods for their preparation |
07/22/2008 | CA2313638C Cyclohexene carboxylates as neuraminidase inhibitors |
07/17/2008 | US20080171870 Reacting 4-Morpholin-4-ylmethyl-benzoic acid with 1-cyclopropyl-piperazine dihydrochloride producing (4-Cyclopropyl-piperazin-1-yl)-(4-morpholin-4-ylmethyl-phenyl)-methanone; sleep disorders, attention deficit hyperactivity disorders (ADHD), learning and memory disorders |
07/17/2008 | US20080171869 Condensation of 10H-dibenzo-[b,f][1,4]-thiazepin-11-one with a piperazine derivative in the presence of a titanium alkoxide catalyst; Titanium catalyst easier to handle, have low toxicity, not chlorinated, much less harmful for the environment |
07/17/2008 | US20080171749 e.g. 2-(4-Cyclohexyl-piperazin-1-yl)-2-(4-methoxy-phenyl)-acetonitril; antiinflammatory, antiallerge agent,autoimmune diseases; asthma, rheumatoid arthritis, atherosclerosis or allergic diseases wherein the activity of a CCR3 receptor is involved |
07/17/2008 | US20080171742 e.g. 6-methyl-2-{2-[3-(pyrid-2-yl)isoxazol-5-yl]pyrrolidin-1-yl}-4-(pyrid-2-ylamino)pyrimidine; insulin-like growth factor 1 receptor (somatomedin) antagonist; antiproliferative, antitumor, anticarcinogenic agent; |
07/17/2008 | US20080171692 Substituted amides |
07/16/2008 | EP1943236A2 Process for the synthesis of amine ethers |
07/16/2008 | EP1943217A1 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
07/16/2008 | EP1943213A2 Ppar modulating biaromatic compounds |
07/16/2008 | CN101220009A Method for producing N-amido piperidine hydrochlorate |
07/16/2008 | CN101220008A Synthesis of compound ABT-263 |
07/16/2008 | CN101220007A Method for producing repaglinide |
07/16/2008 | CN101220006A Buflomedil production method |
07/16/2008 | CN100402496C Compounds useful as matrix metalloprotease inhibitors |
07/16/2008 | CN100402495C Aminoalkylamide substituted cyclohexyl derivatives |